Kirstin Powel, Vice President of Quality Assurance, comes to Talaris from the Novartis Cell and Gene Therapy Unit where she served as Global Head of Quality Operations. In that role she had quality responsibility for the overall supply chain and played a key role in pre-approval inspection preparation and global launch processes for the first FDA-approved CAR-T cell therapy, Kymriah. Ms. Powel was previously employed by Lonza, AG in positions with increasing levels of responsibility in Quality, most recently in the Global Quality organization with global quality oversight for biologics as well as cell and gene therapy products. Ms. Powel holds a B.A. in biochemistry from Rutgers University and an M.S. in physiology from North Carolina State University.